A Boston program through which city workers can buy low-cost Canadian prescription drugs will receive its last shipment of drugs in December, after the Canadian drug supplier terminated its involvement because of a lack of participants, the Boston Globe reports.
Lees meer..

From today, people can access a new authoritative source of information on the Internet about medicines. This new resource is a guide to the life-cycle of new medicines, from their first scientific discovery through to licensing and on-going monitoring. It is available at http://www.mhra.gov.
Lees meer..

Higher levels of testosterone are correlated with financial risk-taking behavior, according to a new study in which men’s testosterone levels were assessed before participation in an investment game. The findings help to shed light on the evolutionary function and biological origins of risk taking.
Lees meer..

Researchers at the Georgia Institute of Technology have developed a computer program that trains itself to predict genes in the DNA sequences of fungi. Fungi - which range from yeast to mushrooms - are important for industry and human health, so understanding the recently sequenced fungal genomes can help in developing and producing critical pharmaceuticals.
Lees meer..

Viruses dramatically increase cellular metabolism, and existing anti-obesity drugs may represent a new way to block these metabolic changes and inhibit viral infection, according to a study published in the journal Nature Biotechnology. Metabolism refers to all the reactions by which living things break down nutrients to produce energy, along with those by which they rebuild broken-down nutrients into complex molecules (e.g. DNA).
Lees meer..

A protein required for the earliest steps in embryonic development also plays a key role in solidifying fear memories in the brains of adult animals, scientists have revealed. An apparent “hub” for changes in the connections between brain cells, beta-catenin could be a potential target for drugs to enhance or interfere with memory formation. The results are published online this week and appear in the October issue of Nature Neuroscience.
Lees meer..

MedImmune Inc. has licensed its reverse genetics technology to the Research Foundation for Microbial Diseases of Osaka University in Japan (BIKEN) for use in influenza vaccine development and production.

Lees meer..

Cephalon will pay $425 million to settle charges that it promoted three of its drugs for uses that were not approved by the Food and Drug Administration. (CEPH)

Lees meer..

MedImmune Inc. has licensed its reverse genetics technology to the Research Foundation for Microbial Diseases of Osaka University in Japan (BIKEN) for use in influenza vaccine development and production.

Lees meer..

Repros Therapeutics Inc. has agreed to sell 2.4 million shares to Efficacy Capital Ltd., its largest shareholder, and an unnamed company for about $15.6 million. (RPRX)

Lees meer..